Research@UIC > Funding Opportunities > Minority-Based Community Clinical Oncology Program Groups (U10)

NIH - Minority-Based Community Clinical Oncology Program Groups (U10)
RFA-CA-11-008

Program Summary

This funding opportunity announcement (FOA) solicits applications for the program known as "Minority-Based Community Clinical Oncology Program" (Minority-Based CCOP/MBCCOP). This program allows practicing oncologists who serve large racial/ethnic minority populations to participate in NCI-sponsored clinical trials. The purpose of this program is to support, as a national resource, research activities of physicians involved in the care of minorities who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials. The NCI clinical trials program supports MBCCOPs by providing access to clinical trials in cancer centers, major university centers, and community programs. The linkage of minority cancer patients/participants to the current NCI clinical trials network facilitates the transfer of new research advancements in cancer prevention/control/treatment practices to minority communities and their physicians. The CCOP Network consists of three components each with its own FOA. The components are as follows: Minority Based-CCOPs (covered by this FOA), CCOP Groups (also referred to as CCOPs), and CCOP Research Bases. A Minority-Based CCOP encompasses community oncologists who accrue patients/participants to NCI-approved clinical trials. These trials are designed and conducted by the CCOP Research Bases, which also manage and analyze the data, and report the results. CCOP Research Bases must be located either at an NCI-supported Clinical Cooperative Group or at an NCI-designated Cancer Center. CCOP was established in 1983 to develop and conduct state-of-the-art cancer prevention, control and treatment clinical trials with significant involvement of community oncologists and populations they serve. The CCOP Network mission includes: (1) accelerating development of interventions to prevent and treat cancer and its symptoms by increasing accrual to trials; (2) fostering quality care in the community through adoption of results from clinical trials; and (3) increasing the involvement of minority and underserved patient/participant populations in cancer clinical trials and associated research.

UIC is restricted to one application.

Additional Information 

http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-11-008.html

Deadlines

Letter of Intent

OVCR may reserve submission slots for previously submitted but unfunded proposals that received highly competitive ratings from the external sponsor. These will be evaluated on a case-by-case basis by the Vice Chancellor. For consideration, scanned copies of your complete reviews (not just summary) must be included with LOI.

Depending upon the number of LOIs submitted, OVCR might be required to facilitate an internal peer review process to select UIC’s submission(s) to this program.  White paper instructions will be posted if necessary.

eLOI Form & Instructions – Adobe Acrobat Requirements

1. Download the file directly to your computer or to a disk, right click on the link, then select "save link as" or "save target as" from the dropdown options.
2. Open eLOI.
3. Position the hand pointer inside a form field and click.
• To accept the field change and go to the next field, press Tab or use your mouse to click on the next form field.
• To accept the field change and go to the previous field, press Shift + Tab or use your mouse to click on the previous form field.
4. Complete the form fields.
5. After completing the form, click “Save” then click “Submit to RDS@uic.edu”.

Letter of Intent (LOI): eLOI Form (Fillable PDF*)

*Please note:

• Fields highlighted in red are required to successfully submit the form.
• Do not print then submit scanned version of e-LOI via email.

Please contact Tony Halford at ahalford@uic.edu or 6-7036 with any questions.

Last updated: